Characterization, Stability and Biological Activity In Vitro of Cathelicidin-BF-30 Loaded 4-Arm Star-Shaped PEG-PLGA Microspheres

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Yueli BaoMinglong Yuan

Abstract

BF-30 is a single chain polypeptide of an N-segment with an α-helix from cathelicidin gene encoding, and it contains 30 amino acid residues, with a relative molecular mass and isoelectric point of 3637.54 and 11.79, respectively. Cathelicidin-BF-30 was entrapped in four-arm star-shaped poly(ethylene glycol-b-dl-lactic acid-co-glycolic acid) block copolymers (4-arm-PEG-PLGA) by a double-emulsion solvent-evaporation method. Three release phases of cathelicidin-BF-30loaded 4-arm-PEG-PLGA microspheres were observed, including an initial burst-release phase, followed by a lag phase with minimal drug release and finally a secondary zero-order release phase. The delivery system released BF-30 over more than 15 days in vitro. Furthermore, the material for preparing the microspheres has good biocompatibility and biodegradability. Additionally, based on the drug resistance of food pathogenic bacteria, the antibacterial effects of BF-30 on Shigella dysenteriae CMCC 51105 (Sh. dysenteriae CMCC 51105), Salmonella typhi (S. typhi) and Staphylococcus aureus (S. aureus) as well as the stability of the in vitro release of the BF-30-loded microspheres were studied. The α-helix secondary structure and antibacterial activity of released BF-30 were...Continue Reading

References

Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H S Yoo, T G Park
Oct 4, 2005·International Journal of Pharmaceutics·Moon Suk KimHai Bang Lee
Apr 28, 2006·Journal of Pharmaceutical Sciences·Ketan Amin, Rose-Marie Dannenfelser
Aug 8, 2006·Current Opinion in Pharmacology·Alexandra K MarrRobert Ew Hancock
Feb 3, 2007·Molecular & Cellular Proteomics : MCP·Jianxu LiJing Wu
May 25, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mingli YeKinam Park
Sep 8, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luisanna OstacoloMichele Caraglia
Oct 5, 2010·Journal of Drug Targeting·Yuan GaoShen Gao
Nov 4, 2010·Journal of Colloid and Interface Science·Zhimei SongGuangxi Zhai
Mar 1, 2011·Colloids and Surfaces. B, Biointerfaces·Wasana ChaisriSiriporn Okonogi
Apr 22, 2011·Journal of Biomedical Materials Research. Part a·Jundong ZhuZheng Wang
Sep 10, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Malin M ZetterbergKatarina Edwards
Apr 6, 2012·Archives of Pharmacal Research·Su-Jin KangBong-Jin Lee
Aug 21, 2012·International Journal of Pharmaceutics·Amélie GaignauxKarim Amighi
Oct 30, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashlee N Ford VersyptRichard D Braatz
Apr 23, 2013·Journal of Biomedical Materials Research. Part a·Ting LingPiyi Du
Oct 12, 2013·Archives of Pharmacal Research·Jing WangChanglin Zhou
Mar 29, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Keru ZhangHaibing He
Sep 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guanghui Ma
Feb 1, 2015·International Journal of Pharmaceutics·F RamazaniR J Kok
Dec 18, 2015·Journal of Materials Science. Materials in Medicine·Guilei MaDeling Kong
Dec 26, 2015·International Journal of Pharmaceutics·Jie ShenDiane J Burgess
Mar 12, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bing GuDiane J Burgess
Feb 6, 2017·Biochimica Et Biophysica Acta. Biomembranes·Bung-On PrajanbanSompong Klaynongsruang

❮ Previous
Next ❯

Citations

Jul 24, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Ankur SharmaRahul Kumar Verma
Apr 25, 2020·Toxins·Clara Pérez-PeinadoDavid Andreu
Sep 29, 2020·Frontiers in Microbiology·Morgan A AlfordRobert E W Hancock
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yi HeCui Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance
scanning electron microscopy
circular dichroism
enzyme-linked immunosorbent assay

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.